Gene · 369
NIH grants1,471
NIH grants whose papers are about the gene, through NIH's grant-paper links.
341 to 360 of 1,471
Download this page as JSON| Grant | Title | ARAF papers | Newest fiscal year |
|---|---|---|---|
| R01CA251138 | Interrogating the minor spliceosome to understand and treat leukemia | 1 | 2024 |
| R01CA251155 | Targeting tumor metabolism and immune environment via beta-catenin: Towards precision medicine in HCC | 1 | 2024 |
| R01CA256557 | A Multi-pronged Computational Approach to Advance Kinase Drug Discovery | 1 | 2024 |
| R01EY032113 | Embryonic vascular stem-progenitors for treatment of ischemic retinopathies | 1 | 2024 |
| R01MH061469 | Molecular Regulation of Metabotropic Glutamate Receptors in Striatal Neurons | 1 | 2024 |
| R21CA267515 | Preventing Therapeutic Resistance in RAS-mutated Pediatric Cancers | 1 | 2024 |
| R35CA220497 | Development of Combination Therapies to Delay/Prevent Acquired Drug Resistance | 1 | 2024 |
| R35CA231998 | Integrating genomics and the protein interactome for HPV+ head and neck cancer therapy | 1 | 2024 |
| R35GM136295 | Mechanisms and functions of Shoc2-transduced cellular signals | 1 | 2024 |
| R35NS097306 | From the spinal cord to the brain: Neurology of the pain and itch neurons | 1 | 2024 |
| R35NS097370 | Functional roles of genetic risk factors for brain disorders in neurogenesis and neurodevelopment | 1 | 2024 |
| R37CA222574 | Molecular origins and evolution to chemoresistance in germ cell tumors | 1 | 2024 |
| RF1AG064909 | Systems Approaches to Novel Molecular Mechanism in Alzheimer's Disease | 1 | 2024 |
| T32EB007507 | Comprehensive Training program in Imaging Science and Informatics | 1 | 2024 |
| T32ES007069 | Training Program in Environmental Epidemiology | 1 | 2024 |
| T32GM008444 | Medical Scientist Training Program | 1 | 2024 |
| T32GM136573 | Medical Scientist Research Service Award | 1 | 2024 |
| UL1TR001412 | University of Buffalo Clinical and Translational Science Institute | 1 | 2024 |
| UL1TR001442 | UC San Diego Clinical and Translational Research Institute | 1 | 2024 |
| UL1TR002001 | The University of Rochester Clinical and Translational Science Award Hub | 1 | 2024 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/369/grants?page=18